Columbia Lab-to-Market Accelerator Network

Columbia Lab-to-Market Accelerator Network is a leading platform dedicated to guiding deep-tech innovation from research to real-world impact. Providing strategic and hands-on support, Columbia Lab-to-Market empowers faculty teams and external innovators working at the frontiers of life sciences, AI, clean energy, diagnostics, smart cities, and more. Columbia Lab-to-Market Accelerator Network serves as a crucial bridge between research and commercialization, empowering teams to navigate the complexities of bringing transformative science to market.

Operating from its primary address in New York, US, Columbia Lab-to-Market has a strong track record of supporting numerous teams, issuing cash awards, and helping launch successful startups. The Columbia Lab-to-Market Accelerator Network’s growing network includes accelerators such as Biomedical Engineering Technology Accelerator (BiomedX), Translational Therapeutics Accelerators (TRx), Accelerating Cancer Therapeutics (ACT), Carbontech Development Initiative, and many more. Columbia Lab-to-Market Accelerator Network has secured substantial external funding to further its mission of advancing scientific breakthroughs.

Columbia Lab-to-Market Accelerator Network continues to expand its initiatives and impact in the deep-tech ecosystem. We invite the management team of Columbia Lab-to-Market Accelerator Network to create a customized and exclusive company showcase and product listing on our platform, enhancing your visibility and reach within the industry.